Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LARGE1 (AA 35-142) Antikörper (PE)

Reaktivität: Human FACS Wirt: Maus Monoclonal LARGE-02 PE
Produktnummer ABIN2749158
  • Target
    LARGE1
    Bindungsspezifität
    AA 35-142
    Reaktivität
    Human
    Wirt
    • 3
    Maus
    Klonalität
    • 3
    Monoklonal
    Konjugat
    • 2
    • 1
    PE
    Applikation
    • 3
    • 3
    Flow Cytometry (FACS)
    Spezifität
    The mouse monoclonal antibody LARGE-02 recognizes human LARGE1, a glycosyltransferase expressed mainly in the Golgi apparatus. Crossreactivity with LARGE2 was not determined.
    Kreuzreaktivität (Details)
    Human
    Aufreinigung
    Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
    Immunogen
    Recombinant fragment of human LARGE1 (amino acids 35-142)
    Klon
    LARGE-02
    Isotyp
    IgG2b
  • Applikationshinweise
    Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.
    Kommentare

    The purified antibody is conjugated with R-Phycoerythrin (PE) under optimum conditions. The conjugate was purified by size-exclusion chromatography.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.1 mg/mL
    Buffer
    Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • Target
    LARGE1
    Hintergrund
    LARGE xylosyl- and glucuronyltransferase 1,LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.,Xysosyl- and glucosyl transferase 1
    Gen-ID
    9215
    UniProt
    O95461
Sie sind hier:
Kundenservice